Friedrich Finckenstein
Chief Tech/Sci/R&D Officer at IOVANCE BIOTHERAPEUTICS, INC.
Net worth: 630 769 $ as of 2024-03-30
Profile
Presently, Friedrich Graf Finckenstein occupies the position of Chief Medical Officer for Iovance Biotherapeutics, Inc. He previously was Global Head-Oncology Translational Medicine at F. Hoffmann-La Roche Ltd. He received a doctorate from the University of Hamburg.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-04-14 | 42,562 ( 0.02% ) | 630 769 $ | 2024-03-30 |
Friedrich Finckenstein active positions
Companies | Position | Start |
---|---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-07-17 |
Former positions of Friedrich Finckenstein
Companies | Position | End |
---|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Training of Friedrich Finckenstein
University of Hamburg | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Friedrich Finckenstein